- Home
- GDYN vs ZVRA Comparison
GDYN vs ZVRA Comparison
Compare GDYN & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDYN | ZVRA |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 653.5M | 562.2M |
| IPO Year | 2018 | 2015 |
Fundamental Metrics
Financial Performance| Metric | GDYN | ZVRA |
|---|---|---|
| Price | $8.23 | $12.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $10.67 | ★ $23.00 |
| AVG Volume (30 Days) | ★ 906.0K | 801.0K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 120.00 | ★ 159.21 |
| EPS | 0.02 | ★ 0.74 |
| Revenue | ★ $111,283,000.00 | $106,470,000.00 |
| Revenue This Year | $10.16 | $37.27 |
| Revenue Next Year | $10.84 | $53.42 |
| P/E Ratio | $399.00 | ★ $16.23 |
| Revenue Growth | N/A | ★ 350.91 |
| 52 Week Low | $5.11 | $7.16 |
| 52 Week High | $10.21 | $15.04 |
Technical Indicators
Market Signals| Indicator | GDYN | ZVRA |
|---|---|---|
| Relative Strength Index (RSI) | 62.45 | 52.74 |
| Support Level | $7.57 | $11.39 |
| Resistance Level | $10.20 | $12.19 |
| Average True Range (ATR) | 0.23 | 0.40 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 93.60 | 45.58 |
Price Performance
Historical ComparisonAbout GDYN Grid Dynamics Holdings Inc.
Grid Dynamics Holdings Inc is a provider of technology consulting, platform and product engineering, and advanced analytics services. The company delivers tailored solutions in several industry verticals like Tech, Media and Telecom, Retail, Finance and Consumer Packaged goods (CPG)/manufacturing. The company derives maximum revenue from Retails. Geographically company earns revenue from North America, Europe and other regions.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.